"On December 16, 2014, the U. S. Food and Drug Administration approved lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroe"...
(Generic versions may still be available.)
(thiethylperazine maleate) Tablets
(thiethylperazine maleate) for Injection, USP
For Intramuscular Use Only
TORECAN (thiethylperazine) is a phenothiazine. Thiethylperazine is characterized by a substituted thioethyl group at position 2 in the phenothiazine nucleus, and a piperazine moiety in the side chain. The chemical designation is: 2-ethyl-mercapto-10-[3 †- (1 †-methyl-piperazinyl-4†)-propyl-1] phenothiazine.
Tablet, 10 mg, for oral administration
Active Ingredient: thiethylperazine maleate USP, 10 mg.
Inactive Ingredients: acacia, carnauba wax, FD&C Yellow No.5 aluminum lake (tartrazine), FD&C Yellow No.6 aluminum lake, gelatin, lactose, magnesium stearate, povidone, sodium benzoate, sorbitol, starch, stearic acid, sucrose, talc, titanium dioxide.
Ampul, 2 ml, for intramuscular administration
Active Ingredient: thiethylperazine malate USP, 10 mg per 2 mL.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Torecan Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.